Dr. Brescia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414
Education & Training
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1969 - 1970- Zucker School of Medicine at Hofstra/NorthwellInternship, Transitional Year, 1968 - 1969
Rutgers New Jersey Medical SchoolClass of 1968
Certifications & Licensure
NJ State Medical License 1974 - Present
SC State Medical License 1998 - 2025
GA State Medical License 1994 - 1999- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2011, 2013-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2010, 2012-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery Start of enrollment: 2005 Sep 21
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers Start of enrollment: 2009 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 34 citationsRemote psychotherapy for terminally ill cancer patients.Jeffrey S. Cluver, Dean Schuyler, B. Christopher Frueh, Frank J. Brescia, George W. Arana
Journal of Telemedicine and Telecare. 2005-04-01 - 44 citationsA Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade ...Sylvia Adams, Megan Othus, Sandip Pravin Patel, Kathy D. Miller, Rashmi Chugh
Clinical Cancer Research. 2021-10-29 - 14 citationsSemiallogeneic cancer vaccines formulated with granulocyte-macrophage colony-stimulating factor for patients with metastatic gastrointestinal adenocarcinomas: a pilot ...Danforth A. Newton, Paula M. Acierno, Margaret C. Metts, Paul L. Baron, Frank J. Brescia
Journal of Immunotherapy. 2001-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
